Home / People / Lauren Gregory
Portrait ofLauren Gregory

Lauren Gregory

Senior Associate

CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
United Kingdom
Languages English

Lauren is a European and UK Patent Attorney who specialises in the fields of molecular biology, immunology and biotechnology. Her practice focuses on patent prosecution, opposition and appeal work before the European Patent Office, including multi-party oppositions. Lauren is also experienced in the management of large European patent portfolios and associated strategic advice.

Lauren has particular expertise and interest in the areas of personalised medicine, peptide-based technology, vaccines, antisense oligonucleotides and gene therapy, antibody and antibody-conjugate technology, PCR technology, biomarkers, transgenic plant biotechnology, recombinant gene expression and stem cells.

Lauren studied natural sciences, specialising in genetics, at the University of Cambridge, and has a PhD in developmental neurobiology from University College London.

more less

Relevant experience

  • Successful defence before the EPO Opposition Division of a CuRNA, Inc patent relating to therapeutic antisense oligonucleotides, resulting in maintenance of the patent as granted.
  • Successful defence before the EPO Opposition Division of a University of Iowa Research Foundation patent relating to therapeutic complement factor H polypeptides, resulting in rejection of the opposition and maintenance of the patent as granted.
  • Experience in multiple oppositions, both offensive and defensive, including defence of large multi-party oppositions.
  • Experience in devising and advising on the prosecution strategy of large and expanding patent portfolios, as well as coordinating the prosecution in multiple countries.
  • Assisting in achieving allowance at the EPO of AbbVie’s patent claims to the dual variable domain immunoglobulin format.
  • Assisting in achieving grant at the EPO of MedImmune’s (Astra Zeneca) anti-PD1 antibody patent.
more less

Memberships & Roles

Member of CIPA and EPI

more less


2015 - Certificate in Basic Litigation Skills

2015 – EPA (European Patent Attorney)

2014 – CPA (Chartered Patent Attorney) 

2011 – PhD (Developmental Neurobiology), UCL

2007 – BA (Natural Sciences - Genetics), University of Cambridge

more less


AI in healthcare inventions – technical or not technical?
SummaryRecent European Patent Office (EPO) Board of Appeal case T 1910/20 sits among a number of decisions regarding the discussion of what constitutes technical character in the field of healthcare...
In View: The Unified Patents Court and the Unitary Patent – are you ready?
CMS are delighted to invite you to the next instalment of our Life Sciences & Healthcare update webinar, where experts from across the firm will discuss key industry topics impacting, innovating and disrupting...
New EPO Guidelines now published regarding amending the description: what’s...
Introduction In October 2020, CMS published an article ‘New EPO Guidelines expected regarding amending a description: what’s all the fuss about?’, which has been the catalyst for discussion in the...
New EPO Guidelines expected regarding amending a description: what’s all...
SummaryThe EPO requirement to amend the description to conform with allowed claims is changing significantly. Examiners have already been given internal guidance and revisions to the EPO Guidelines for...
An EPO Case Law Round-Up: Added Matter
The EPO is well-known for its strict approach to assessing amendments under the added matter provision of Article 123 of the European Patent Convention. This often creates complex legal scenarios which...
T 1621/16 - the Board of Appeal clarifies added matter assessment with...
In the recent appeal decision T 1621/16 concerning Proctor & Gamble's application EP 2264138, which relates to a hand dishwashing liquid, the Board of Appeal has provided greater clarity regarding the...